Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

the Value of Immunohistochemical Expression of Moesin in Endometrial Hyperplasia and Endometrial Carcinoma

NCT05619159 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT05619159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05619159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
the Value of Immunohistochemical Expression of Moesin in Endometrial Hyperplasia and Endometrial Carcinoma
Lead sponsor
Sohag University
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2022
Completion date
May 31, 2023
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer and endometrial hyperplasia